Bottle
Latest Bristol-Myers Squibb Company Patents:
- TREATMENT OF RENAL CELL CARCINOMA
- METHODS OF TREATING A TUMOR USING AN ANTI-PD-1 ANTIBODY
- Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-D3) pyridazine-3-carboxamide
- Galectin-3 inhibitors
- OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF
Description
FIG. 1 is a front perspective view of our new design of a bottle;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a right side elevational view thereof;
FIG. 4 is a left side elevational view thereof;
FIG. 5 is a top plan view thereof; and,
FIG. 6 is a bottom view thereof.
The broken line showing of a bottle cap is for illustrative purposes only and does not form part of the claimed design.
Referenced Cited
Patent History
Patent number: D336733
Type: Grant
Filed: Aug 27, 1991
Date of Patent: Jun 22, 1993
Assignee: Bristol-Myers Squibb Company (New York City, NY)
Inventor: Frederick B. Hadtke (New Providence, NJ)
Primary Examiner: Bernard Ansher
Assistant Examiner: Lucy Lieberman
Attorney: Anthony M. Santini
Application Number: 7/752,231
Type: Grant
Filed: Aug 27, 1991
Date of Patent: Jun 22, 1993
Assignee: Bristol-Myers Squibb Company (New York City, NY)
Inventor: Frederick B. Hadtke (New Providence, NJ)
Primary Examiner: Bernard Ansher
Assistant Examiner: Lucy Lieberman
Attorney: Anthony M. Santini
Application Number: 7/752,231
Classifications
Current U.S. Class:
D/9522;
D/9516;
D/9563